Michael D West - Net Worth and Insider Trading
Michael D West Net Worth
The estimated net worth of Michael D West is at least $1 Million dollars as of 2024-05-05. Michael D West is the Co-CEO of Lineage Cell Therapeutics Inc and owns about 882,864 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $935,836. Michael D West is also the CEO of AgeX Therapeutics Inc and owns about 15,460 shares of AgeX Therapeutics Inc (AGE) stock worth over $171,606. Details can be seen in Michael D West's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael D West has not made any transactions after 2018-12-10 and currently still holds the listed stock(s).
Transaction Summary of Michael D West
Michael D West Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael D West owns 5 companies in total, including AgeX Therapeutics Inc (AGE) , Lineage Cell Therapeutics Inc (LCTX) , and OncoCyte Corp (OCX) among others .
Click here to see the complete history of Michael D West’s form 4 insider trades.
Insider Ownership Summary of Michael D West
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AGE | AgeX Therapeutics Inc | 2018-12-10 | director & Chief Executive Officer |
LCTX | Lineage Cell Therapeutics Inc | 2017-08-22 | director |
OCX | OncoCyte Corp | 2015-12-30 | director |
2015-02-13 | director & VP of Technology Integration | ||
2007-10-09 | director |
Michael D West Latest Holdings Summary
Michael D West currently owns a total of 2 stocks. Among these stocks, Michael D West owns 882,864 shares of Lineage Cell Therapeutics Inc (LCTX) as of August 22, 2017, with a value of $935,836 and a weighting of 84.5%. Michael D West also owns 15,460 shares of AgeX Therapeutics Inc (AGE) as of December 10, 2018, with a value of $171,606 and a weighting of 15.5%.
Latest Holdings of Michael D West
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LCTX | Lineage Cell Therapeutics Inc | 2017-08-22 | 882,864 | 1.06 | 935,836 |
AGE | AgeX Therapeutics Inc | 2018-12-10 | 15,460 | 11.10 | 171,606 |
Holding Weightings of Michael D West
Michael D West Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael D West has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 2,000 shares on August 22, 2017, which cost Michael D West around $5,200.
According to the SEC Form 4 filings, Michael D West has made a total of 0 transactions in AgeX Therapeutics Inc (AGE) over the past 5 years. The most-recent trade in AgeX Therapeutics Inc is the acquisition of 4,000 shares on December 10, 2018, which cost Michael D West around $15,440.
Insider Trading History of Michael D West
- 1
Michael D West Trading Performance
GuruFocus tracks the stock performance after each of Michael D West's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael D West is 1.87%. GuruFocus also compares Michael D West's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael D West within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael D West's insider trading performs compared to the benchmark.
Performance of Michael D West
Michael D West Ownership Network
Ownership Network List of Michael D West
Ownership Network Relation of Michael D West
Michael D West Owned Company Details
What does AgeX Therapeutics Inc do?
Who are the key executives at AgeX Therapeutics Inc?
Michael D West is the director & Chief Executive Officer of AgeX Therapeutics Inc. Other key executives at AgeX Therapeutics Inc include director & 10 percent owner Juvenescence Us Corp. , Chief Financial Officer Park Andrea Eun Jae , and Chief Financial Officer Russell Skibsted .
AgeX Therapeutics Inc (AGE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AgeX Therapeutics Inc (AGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AgeX Therapeutics Inc (AGE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AgeX Therapeutics Inc (AGE)'s detailed insider trading history can be found in Insider Trading Tracker table.
AgeX Therapeutics Inc Insider Transactions
Michael D West Mailing Address
Above is the net worth, insider trading, and ownership report for Michael D West. You might contact Michael D West via mailing address: Agex Therapeutics, Inc., 1101 Marina Village Parkway, Suite 201, Alameda Ca 94501.